Two departments issued a document to guidethe strengthening of drug cases investigation and handling
According to the State DrugAdministration website, a few days ago, the State Drug Administration and theGeneral Administration of Market Regulation jointly issued the "Opinionson further strengthening the investigation of drug cases," to strengthenthe case investigation work norms and guidance, improve the case investigationwork mechanism, the implementation of drug safety responsibilities, severepunishment for illegal and criminal acts in the field of drugs, medicaldevices, cosmetics. To thoroughly implement the important instructions ofGeneral Secretary Xi Jinping and the Party Central Committee, the StateCouncil's decision-making arrangements, the State Drug Administration isorganizing the entire system to carry out a year of drug safety specialrectification action, case investigation work is an important means to combatdrug violations.
"Opinions" from four aspects ofthe case investigation work to make comprehensive arrangements, requiring drugregulatory departments at all levels to build clear responsibilities, orderly,scientific and reasonable, closely linked to the case investigation workmechanism. The "Opinions" clearly, regulatory departments at alllevels to establish a new era of law enforcement case concept, scientificdivision of case investigation authority, reasonable allocation of caseinvestigation resources, strengthen the case investigation and coordination, totake more resolute and strong measures to severely investigate and deal withall kinds of drug violations. The "Opinions" stressed the need toaddress the outstanding issues strongly reflected by the public, activelyinvestigate the case clues, standardize the case investigation and evidencecollection procedures, strict implementation of administrative penalties,standardize the discretion of administrative penalties, and continue to enhancethe effectiveness of the investigation and handling of cases. The"Opinions" require the strict implementation of violations of the"punishment to the person" provisions, improve the interface betweenthe executive and the criminal mechanism, the overall coordination of majorcases of risk prevention and control, steadily promote the case investigationand handling of information disclosure, timely adoption of effective riskcontrol measures, and comprehensively improve the transparency of lawenforcement, standardization and credibility. The "Opinions" proposedto strengthen the inspection and inspection synergy, strengthen the casesupervision and supervision, strengthen the case investigation and evaluationof a number of initiatives to improve the quality and ability of the caseinvestigation and handling cadres, to create a good atmosphere to encourageregulatory law enforcement officers to take charge, dare to takeresponsibility, strict law enforcement.
The development and release of the"Opinions" will better promote the "two laws and tworegulations" and the newly revised "Administrative Penalty Law"on the ground implementation, a strong boost to drug safety special rectificationwork to achieve effective results, and effectively guard the people's healthand life safety.
Looking for chemical products? Let suppliers reach out to you!
2026-07-18
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
6th Drug Safety Symposium 2026 to Focus on “Beyond Algorithms & Assumptions, What Actually Matters in Pharmacovigilance”
-
Roche Acquires Carmot for $3.1 Billion to Enter Obesity Drug Market
-
National Health Care Commission: 50% of thecountry's public hospitals above the second level have carried out appointmentdiagnosis and treatment services
-
India starts testing a pharmaceuticalcompany's exports of cough syrup
-
Inmanar Announces Several BreakthroughSequencing Innovations
-
China's medical supplies supply securitycapabilities continue to enhance
-
244 medical device concept stocks roseindustry insiders said the process of domestic replacement is expected toaccelerate
-
Rare diseases pose a challenge to thepharmaceutical industry
-
Pfizer's $11.6 Billion Double-acting Migraine Drug Generates $318 Million in First-half Revenue
-
An Insight Into Top 5 Environmental Impact Of Drugs
Recommend Reading
-
Pfizer Warns Germany Over Drug-Pricing Policy
-
India Raises Cancer Drug Price Caps by 50%
-
Novo Nordisk Reports Theft of Six Drug Batches in India Authorities Warn of Severe Patient Safety Risks
-
Roche Keeps German Diagnostics Investment
-
Glenmark Recalls Over 110000 Bottles of BP and COPD Drugs in US Due to Safety Concerns
-
Premium Global Chemical Sourcing Requests (19 - 22 Mar, 2026)
-
October China Soda Ash Market Trend Consolidates
-
October Petrocoke Prices Continue to Rise
-
Premium Global Chemical Sourcing Requests (15-19 Nov 2025)
-
The Last 10% Tariff Trap: A New Chapter in U.S.–China Negotiations on “Fentanyl Tariffs”